A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

NCT03854617 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

172

Enrollment

OTHER

Sponsor class

Conditions

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions

DRUG: Oral NVB Metronomic
DRUG: Oral NVB Weekly

Sponsor

Chinese Academy of Medical Sciences